在安卡拉的新结核病例中对药物坚持的评估:前性队列研究
Sahin Can Ozaltun1, Levent Akin1
1Department of Public Health, Faculty of Medicine, Hacettepe University, Ankara 06230, Türkiye.
Healthcare (Basel, Switzerland)
|December 17, 2024
概括
结核病药物坚持在治疗期间下降. 诸如每天获得药物和工作场所灵活性等因素可以提高坚持. 针对性干预对于治疗成功至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 不遵守结核病药物治疗带来重大风险,包括治疗失败,持续的传染性和耐药性.
- 了解影响坚持的因素对于实现全球结核病治疗成功目标至关重要.
研究的目的:
- 研究影响患者坚持结核病药物治疗的多方面的因素.
- 确定遵守的关键决定因素,以告知有针对性的公共卫生干预措施.
主要方法:
- 一项前性队列研究,涉及三家结核病诊所 (TBD) 的参与者.
- 通过面对面的后续访问收集的数据每两个月进行三次访问.
- 使用概括估计方程分析的自我报告的坚持数据.
主要成果:
- 在强化阶段,坚持率最高 (81.0%),在继续阶段下降 (69.4%至71.1%).
- 与更好的坚持相关的因素包括感染性的知识,每日药物获取,工作场所的灵活性,更高的收入,定期睡眠,肺外结核病,中等教育和减少酒精消费.
结论:
- 结核病药物不服是普遍存在的,特别是在延续阶段.
- 干预措施应应对遗忘,药物不良反应和工作场所的不灵活性.
- 针对结核病传染性和坚持风险的个性化教育,以及持续的支持,可以改善治疗结果.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211


